Stem cell therapy explored for long COVID relief

NCT ID NCT04798066

NO_LONGER_AVAILABLE Disease control Sponsor: Hope Biosciences Research Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental stem cell treatment (HB-adMSCs) added to standard care for people aged 18-65 with Post-COVID-19 syndrome. Participants had not fully recovered weeks or months after a positive COVID-19 test. The goal was to see if the treatment is safe and helps ease lingering symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-COVID-19 SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-COVID-19 SYNDROME

Contacts and locations

Locations

Hope Biosciences Stem Cell Research Foundation

Sugar Land, Texas, 77478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.